Questions discussed in this category
For example, concerning throbocytopenia or neutropenia during anal cancer treatment with concurrent mitomycin/5FU, or other pelvic malignancies treate...
In your practice, what is the proportion of patients receiving neoadjuvant chemotherapy who are diagnosed with VTE? Does this differ from patients rec...
(Normal oxygenation and echo)
Is there a specific brand or formulation you prefer?
The literature supporting the use of probiotics does not standardize the type or dose of probiot...
What is the impact among patients and providers?
Has your documentation been adjusted now that patients can readily review?
In follow up to @Jacqueline Casillas presentation at ASCO 2021 regarding models of survivorship care delivery for AYA patients.
Specifically, are there strategies you use to 1) empower patients to participate in decision-making and 2) reassure patients who may be skeptical?
1673217158156851507914409128921281712224126921256612331101149207901183237059
Papers discussed in this category
J Clin Oncol, 2020 Feb 10
Blood, 2008-05-15
The New England journal of medicine, 2019-02-21
J Thromb Haemost, 2019 Jul 28
N Engl J Med, 2018 Dec 04
Cancer Cell, 2020 Oct 08
J Gen Intern Med, 2021 Feb 02
JAMA Netw Open, 2020 Jun 01
Practical radiation oncology, 2019-03
Blood Adv, 2017 Jun 22
Haematologica, 2019 Jan 03
The lancet. Diabetes & endocrinology, 2019 Aug 22
Journal of the National Cancer Institute, 2013-08-21
Journal of the National Cancer Institute, 2018-01-01
JAMA oncology, 2021 May 01
Antioxidants & redox signaling, 2020 Aug 07
Journal of experimental & clinical cancer research : CR, 2020 Oct 07
BMJ (Clinical research ed.), 2000 Nov 04